These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7115357)

  • 1. Hollow-fiber reactors containing mammalian arginase: an approach to enzyme replacement therapy.
    Kanalas JJ; Spector EB; Cederbaum SD
    Biochem Med; 1982 Feb; 27(1):46-55. PubMed ID: 7115357
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperargininemia: the rat as a model for the human disease and the comparative response to enzyme replacement therapy with free arginase and arginase-loaded erythrocytes in vivo.
    Adriaenssens K; Karcher D; Marescau B; Van Broeckhoven C; Lowenthal A; Terheggen HC
    Int J Biochem; 1984; 16(7):779-86. PubMed ID: 6468738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of enzyme-loaded erythrocytes in in-vitro correction of arginase-deficient erythrocytes in familial hyperargininemia.
    Adriaenssens K; Karcher D; Lowenthal A; Terheggen HG
    Clin Chem; 1976 Mar; 22(3):323-6. PubMed ID: 1253407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argocytes containing enzyme nanoparticles reduce toxic concentrations of arginine in the blood.
    Kaminsky YG; Kosenko EA
    Bull Exp Biol Med; 2012 Jul; 153(3):406-8. PubMed ID: 22866323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsuccessful trial of gene replacement in arginase deficiency.
    Terheggen HG; Lowenthal A; Lavinha F; Colombo JP; Rogers S
    Z Kinderheilkd; 1975; 119(1):1-3. PubMed ID: 164740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoenzyme pattern and immunological properties of arginase in normal and hyperargininemia fibroblasts.
    Konarska L; Wiesmann U; von Fellenberg R; Colombo JP
    Enzyme; 1983; 29(1):44-53. PubMed ID: 6404622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification, modification, physico-chemical and pharmacokinetic characterization of arginase, an enzyme of potential use in therapy.
    Visco C; Benassi CA; Veronese FM; Miglioli PA
    Farmaco Sci; 1987 Aug; 42(8):549-59. PubMed ID: 3117587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of arginase immobilized in a fibrin clot.
    Diez A; Campo ML; Soler G
    Biotechnol Appl Biochem; 1990 Jun; 12(3):237-44. PubMed ID: 2360989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme.
    Grody WW; Kern RM; Klein D; Dodson AE; Wissman PB; Barsky SH; Cederbaum SD
    Hum Genet; 1993 Mar; 91(1):1-5. PubMed ID: 8454280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human salivary arginase and its deficiency in argininaemia.
    Konarska L; Tomaszewski L; Colombo JP; Terheggen HG
    J Clin Chem Clin Biochem; 1985 Jun; 23(6):337-42. PubMed ID: 4020330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperargininemia with arginase deficiency.
    Cederbaum SD; Shaw KN; Spector EB; Verity MA; Snodgrass PJ; Sugarman GI
    Pediatr Res; 1979 Jul; 13(7):827-33. PubMed ID: 481955
    [No Abstract]   [Full Text] [Related]  

  • 12. A new case of arginase deficiency in a Spanish male.
    Jordá A; Rubio V; Portolés M; Vilas J; García-Piño J
    J Inherit Metab Dis; 1986; 9(4):393-7. PubMed ID: 3104676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of hyperargininemia: structure-function consequences of mutations in human liver arginase.
    Ash DE; Scolnick LR; Kanyo ZF; Vockley JG; Cederbaum SD; Christianson DW
    Mol Genet Metab; 1998 Aug; 64(4):243-9. PubMed ID: 9758714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperargininemia, epilepsy and the metabolism of guanidino compounds.
    Wiechert P; Marescau B; De Deyn PP; Lowenthal A
    Padiatr Grenzgeb; 1989; 28(2):101-6. PubMed ID: 2657590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microinjection of arginase into enzyme-deficient cells with the isolated glycoproteins of Sendai virus as fusogen.
    Kruse CA; Spector EB; Cederbaum SD; Wisnieski BJ; Popják G
    Biochim Biophys Acta; 1981 Jul; 645(2):339-45. PubMed ID: 6268159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of erythrocyte arginase protein in Japanese patients with hyperargininemia.
    Hayakawa C; Aono S; Keino H; Mizutani N; Watanabe K; Ikemoto M; Totani M; Murachi T; Kashiwamata S
    Eur J Pediatr; 1991 Sep; 150(11):800-3. PubMed ID: 1959545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human arginases and arginase deficiency.
    Iyer R; Jenkinson CP; Vockley JG; Kern RM; Grody WW; Cederbaum S
    J Inherit Metab Dis; 1998; 21 Suppl 1():86-100. PubMed ID: 9686347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human hyperargininemia: a mutation not expressed in skin fibroblasts?
    Van Elsen AF; Leroy JG
    Am J Hum Genet; 1977 Jul; 29(4):350-5. PubMed ID: 879168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mutations (D128G, H141L) in the liver arginase gene of patients with hyperargininemia.
    Vockley JG; Tabor DE; Kern RM; Goodman BK; Wissmann PB; Kang DS; Grody WW; Cederbaum SD
    Hum Mutat; 1994; 4(2):150-4. PubMed ID: 7981719
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dynamics of arginase activity of granulation tissue in aseptic wound healing and its effect on the reparative process].
    Mamedov LA; Malakhovskiĭ VK; Rebrova TT; Zakharov VV
    Patol Fiziol Eksp Ter; 1988; (2):75-8. PubMed ID: 3412814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.